4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-054352
CEO and Chairman sold 92,540 shares at an average $50.13 ($4,639,102)
- CEO and Chairman acquired 92,540 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-10-06 | Option exercise | +18,280 | $0.33 | $6,032 | 1,796,460 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-06 | Sale | −10,178 | $48.99 | $498,620 | 1,786,282 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-06 | Sale | −8,102 | $49.83 | $403,723 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-07 | Option exercise | +50,000 | $0.33 | $16,500 | 1,828,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-07 | Sale | −1,200 | $49.40 | $59,280 | 1,826,980 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-07 | Sale | −48,800 | $50.20 | $2,449,760 | 1,778,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-08 | Option exercise | +24,260 | $0.33 | $8,006 | 1,802,440 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-08 | Sale | −22,860 | $50.56 | $1,155,802 | 1,779,580 | D |
| ROBINS CHAD M CEO and Chairman | 2020-10-08 | Sale | −1,400 | $51.37 | $71,918 | 1,778,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-10-06 | Option exercise · Stock Option (Right to Buy) | −18,280 | 173,860 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-10-07 | Option exercise · Stock Option (Right to Buy) | −50,000 | 123,860 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-10-08 | Option exercise · Stock Option (Right to Buy) | −24,260 | 99,600 | D | ||
| Open-market sales · 92,540 sh · avg $50.13 · $4,639,102 | |||||||
Loading xslF345X03/doc4.xml…